GSE63471Implementing whole genome array for clinical use in academic centers: A randomized trial comparing neoadjuvant standard chemotherapy to genomic-driven chemotherapy in operable breast cancer (REMAGUS04 trial)
Homo sapiens
142 Downloadable Samples
Affymetrix Human Genome U133A 2.0 Array (hgu133a2)Submitter Supplied Information
Description
REMAUS04 is a phase III trial comparing DNA array-based chemotherapy (by DLD30 score and TOP2A expression) to standard neoadjuvant chemotherapy, in patients with HER2-negative breast carcinoma not eligible for conserving surgery.
PubMed ID
No associated PubMed ID
Publication Title
No associated publication
Total Samples
142
Submitter’s Institution
Authors
No associated authors
Source Repository
Alternate Accession IDs
Samples
Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Age
Disease stage
Processing Information
Additional Metadata
Loading...
Some fields may be harmonized. Learn more